{"url_path":"/sec/mane/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1827635/0001827635-26-000028-index.html","accession_number":"0001827635-26-000028","cik":"0001827635","ticker":"MANE","issuer_name":"Veradermics, Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1827635/0001827635-26-000028-index.html","primary_entity_key":"0001827635","primary_entity_name":"Veradermics, Inc"},"word_count":91,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n99.1\n[Press release issued by the Company on August 11, 2026 regarding financial results for the quarter ended June 30, 2026](ex991q226earnings.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nVERADERMICS, INCORPORATED\n\nBy:/s/ Reid Waldman, M.D.\n\nName: Reid Waldman, M.D.\n\nTitle: Chief Executive Officer\n\nDate: August 11, 2026"}